These results suggest that DNGR-1-mediated recognition of F-actin exposed by dead cancer cells favors priming of CD8+ T cells specific for cytoskeletal neoantigens, which can then drive immune escape of cancer cells lacking or reverting those mutations. Here, CLEC9A is linked to cancer.